A highly sensitive method for the detection of PKC412 (CGP41251) and its metabolites by high-performance liquid chromatography.
Illmer T, Thiede HM, Thiede C, Bornhäuser M, Schaich M, Schleyer E, Ehninger G.
J Pharmacol Toxicol Methods. 2007 Jul-Aug;56(1):23-7. Epub 2007 Feb 23.

Pharmacokinetics of intravenous mycophenolate mofetil after allogeneic blood stem cell transplantation.
Jenke A, Renner U, Richte M, Freiberg-Richter J, Platzbecker U, Helwig A, Thiede HM, Schäfer-Eckart K, Ehninger G, Bornhäuser M.
Clin Transplant. 2001 Jun;15(3):176-84.

Clinical resistance to the kinase inhibitor PKC412 in acute myeloid leukemia by mutation of Asn-676 in the FLT3 tyrosine kinase domain.
Heidel F, Solem FK, Breitenbuecher F, Lipka DB, Kasper S, Thiede MH, Brandts C, Serve H, Roesel J, Giles F, Feldman E, Ehninger G, Schiller GJ, Nimer S, Stone RM, Wang Y, Kindler T, Cohen PS, Huber C, Fischer T.
Blood. 2006 Jan 1;107(1):293-300. Epub 2005 Sep 8.

Determination of mycophenolic acid and mycophenolate mofetil by high-performance liquid chromatography using postcolumn derivatization.
Renner UD, Thiede C, Bornhäuser M, Ehninger G, Thiede HM.
Anal Chem. 2001 Jan 1;73(1):41-6.

Mycophenolate mofetil and cyclosporine as graft-versus-host disease prophylaxis after allogeneic blood stem cell transplantation.
Bornhäuser M, Schuler U, Pörksen G, Naumann R, Geissler G, Thiede C, Schwerdtfeger R, Ehninger G, Thiede HM.
Transplantation. 1999 Feb 27;67(4):499-504.

Inhibition of MAO and COMT by hypericum extracts and hypericin.
Thiede HM, Walper A.
J Geriatr Psychiatry Neurol. 1994 Oct;7 Suppl 1:S54-6.

Effect of dietary salt restriction on urinary serotonin and 5-hydroxyindoleacetic acid excretion in man.
Sharma AM, Schorr U, Thiede HM, Distler A.
J Hypertens. 1993 Dec;11(12):1381-6.

Different effects of eicosapentaenoic acid and olive oil on blood pressure, intracellular free platelet calcium, and plasma lipids in patients with essential hypertension.
Passfall J, Philipp T, Woermann F, Quass P, Thiede M, Haller H.
Clin Investig. 1993 Aug;71(8):628-33.

Effects of sodium salts on pressor reactivity in salt-sensitive men.
Sharma AM, Schattenfroh S, Thiede HM, Oelkers W, Distler A.
Hypertension. 1992 Jun;19(6 Pt 1):541-8.

Comparative investigation of the effect of moclobemide and toloxatone on monoamine oxidase activity and psychometric performance in healthy subjects.
Dingemanse J, Berlin I, Payan C, Thiede HM, Puech AJ.
Psychopharmacology (Berl). 1992;106 Suppl:S68-70.

Hyperreninemia and secondary hyperaldosteronism in a patient with pheochromocytoma and von Hippel-Lindau disease.
Lenz T, Thiede HM, Nussberger J, Atlas SA, Distler A, Schulte KL.
Nephron. 1992;62(3):345-50.

Somatostatin-induced hyperkalemia in a patient on maintenance hemodialysis.
Sharma AM, Thiede HM, Keller F.
Nephron. 1991;59(3):445-8.

Comparison of the monoamine oxidase inhibiting properties of two reversible and selective monoamine oxidase-A inhibitors moclobemide and toloxatone, and assessment of their effect on psychometric performance in healthy subjects.
Berlin I, Zimmer R, Thiede HM, Payan C, Hergueta T, Robin L, Puech AJ.
Br J Clin Pharmacol. 1990 Dec;30(6):805-16.

Role of atrial natriuretic factor in changes in the responsiveness of aldosterone to angiotensin II secondary to sodium loading and depletion in man.
Tuchelt H, Eschenhagen G, Bähr V, Schwietzer G, Thiede HM, Oelkers W.
Clin Sci (Lond). 1990 Jul;79(1):57-65.

Effect of erythropoietin on parameters of sympathetic nervous activity in patients undergoing chronic haemodialysis.
Fritschka E, Neumayer HH, Seddighi S, Thiede HM, Distler A, Philipp T.
Br J Clin Pharmacol. 1990;30 Suppl 1:135S-138S.

Alpha 2- and beta 2-adrenoceptor downregulation in marathon runners.
Schultz KD, Fritschka E, Kribben A, Rothschild M, Thiede HM, Distler A, Philipp T.
J Hypertens Suppl. 1989 Dec;7(6):S48-9.

Combined beta 1-adrenoceptor blockade and/or beta 2- or beta 1/2 adrenoceptor stimulation as treatment of essential hypertension.
Schulte KL, Meyer-Sabellek W, Thiede HM, Röcker L, Gotzen R.
J Hypertens Suppl. 1988 Dec;6(4):S658-61.

Ouabain-induced elevation in forearm vascular resistance, calcium entry and alpha-adrenoceptor blockade, and release and removal of noradrenaline.
Schulte KL, van Gemmeren D, Thiede HM, Meyer-Sabellek W, Gotzen R, Distler A.
J Hypertens Suppl. 1987 Dec;5(5):S215-8.

Platelet intracellular free calcium and hypertension.
Haller H, Lenz T, Thiede M, Lüdersdorf M, Kribben A, Distler A, Philipp T.
J Clin Hypertens. 1987 Mar;3(1):12-9.

Regulation of alpha 2-adrenoceptor density in normotensive and hypertensive man.
Fritschka E, Kribben A, Hoyer J, Rothschild M, Thiede HM, Distler A, Philipp T.
J Hypertens Suppl. 1987 Dec;5(5):S349-52.

Beta-adrenoceptor stimulating and blocking agents in essential hypertension: single and combined therapy with terbutaline and metoprolol.
Schulte KL, Meyer-Sabellek W, Thiede HM, Röcker L, Gotzen R.
Int J Clin Pharmacol Ther Toxicol. 1987 Oct;25(10):539-44.

Sympathetic nervous activity and noradrenaline reactivity during angiotensin converting enzyme inhibition.
Philipp T, Sharma AM, Thiede HM, Kribben A.
Am J Cardiol. 1987 Apr 24;59(10):55D-59D.

Effects of acute hypermagnesaemia on intracellular calcium concentration and adrenergic activity.
Lenz T, Haller H, Lüdersdorf M, Thiede HM, Kribben A, Jendroska K, Distler A, Philipp T.
Clin Sci (Lond). 1987 Jan;72(1):131-4.

Antihypertensive and metabolic effects of diltiazem and nifedipine.
Schulte KL, Meyer-Sabellek WA, Haertenberger A, Thiede HM, Roecker L, Distler A, Gotzen R.
Hypertension. 1986 Oct;8(10):859-65.

Intracellular free calcium and ionized plasma calcium during mineralocorticoid-induced blood pressure increase in man.
Haller H, Thiede M, Lenz T, Lüdersdorf M, Harwig S, Distler A, Philipp T.
J Hypertens Suppl. 1985 Dec;3(3):S41-3.

Free intracellular calcium in essential hypertension. Effects of nifedipine and captopril.
Lenz T, Haller H, Lüdersdorf M, Kribben A, Thiede M, Distler A, Philipp T.
J Hypertens Suppl. 1985 Dec;3(3):S13-5.

Sympathetic tone and pressor response to noradrenaline during mineralocorticoid-induced blood pressure rise in man.
Distler A, Haller H, Harwig S, Kribben A, Lüdersdorf M, Thiede M, Fritschka E, Philipp T.
J Hypertens Suppl. 1985 Dec;3(4):S27-32.

[Ambulatory noradrenaline infusion in refractory Shy-Drager syndrome]
Kribben A, Fritschka E, Philipp T, Thiede HM, Distler A.
Schweiz Rundsch Med Prax. 1985 Apr 16;74(16):407-10. German. No abstract available.

Crossover comparison of nitrendipine with propranolol in patients with essential hypertension.
Fritschka E, Distler A, Gotzen R, Thiede HM, Philipp T.
J Cardiovasc Pharmacol. 1984;6 Suppl 7:S1100-4.

Hypotensive action of calcium antagonists as related to plasma noradrenaline and reactivity to noradrenaline.
Schwietzer G, Distler A, Reeck S, Thiede HM, Philipp T.
J Hypertens Suppl. 1983 Dec;1(2):102-4.

Catecholamine metabolism in rat brain following the intracerebroventricular administration of cyclic nucleotides.
Kehr W, Debus G, Thiede HM.
J Neural Transm. 1982;55(1):1-8.

Catecholamine metabolism in rat brain. The role of neutral and acidic catechol metabolites.
Thiede HM, Kehr W.
Naunyn Schmiedebergs Arch Pharmacol. 1981 Dec;318(1):29-35. No abstract available.

Conjoint radioenzymatic measurement of catecholamines, their catechol metabolites and DOPA in biological samples.
Thiede HM, Kehr W.
Naunyn Schmiedebergs Arch Pharmacol. 1981 Dec;318(1):19-28.

Endogenous dopa in rat brain. Occurrence, distribution and relationship to changes in catecholamine synthesis.
Thiede HM, Kehr W.
Naunyn Schmiedebergs Arch Pharmacol. 1981 Jul;316(4):299-303.

Methoxytyrosine formation as an indicator of catechol-O-methyltransferase activity in rat liver in vivo.
Kehr W, Zimmermann R, Thiede M.
Naunyn Schmiedebergs Arch Pharmacol. 1977 Oct;300(1):19-23.

[Methodology of repeated arterial blood pressure determination in awake dogs in view of long-term systemic tolerance tests]
Sedlacek H, Günzel P, Wiemann H, Thiede HM.
Z Versuchstierkd. 1973;15(5):332-41. German. No abstract available.